Featured Research

from universities, journals, and other organizations

Membrane protein mystery solved: May lead to better treatments for people with learning deficits

Date:
June 10, 2011
Source:
University of Wisconsin-Madison
Summary:
A research team has solved a 25-year mystery that may lead to better treatments for people with learning deficits and mental retardation. Synaptophysin is the first protein and most abundant ever found on the membranes surrounding the tiny sacs that carry chemical messengers to synapses, the gaps where communication between nerve cells occurs. But even though the loss of synaptophysin has recently been linked to learning deficits and mental retardation, scientists have been unable for more than a quarter-century to explain what it actually does. Now researchers have shown that synaptophysin controls the replacement of the constantly needed sacs, also known as vesicles.

A University of Wisconsin-Madison research team has solved a 25-year mystery that may lead to better treatments for people with learning deficits and mental retardation.

Synaptophysin is the first protein and most abundant ever found on the membranes surrounding the tiny sacs that carry chemical messengers to synapses, the gaps where communication between nerve cells occurs. But even though the loss of synaptophysin has recently been linked to learning deficits and mental retardation, scientists have been unable for more than a quarter-century to explain what it actually does.

Now UW-Madison researchers have shown that synaptophysin controls the replacement of the constantly needed sacs, also known as vesicles. The study, appearing in the current issue of the journal Neuron, may lead to future drugs that could restore normalcy when vesicles are not utilized efficiently.

"Vesicles are at the heart of fusion, the fundamental process by which information is exchanged between and inside all cells in the body," says Edwin Chapman, a Howard Hughes Medical Institute professor at the UW-Madison School of Medicine and Public Health.

In the nervous system Chapman's team studied, the process begins when an impulse triggers exocytosis -- that is, when a vesicle releases neurotransmitter at the synapse. Then a receiving neuron on the other side of the synapse binds to the neurotransmitter and activates a signal. To wrap up the first phase, the spent vesicle is incorporated into the donor cell membrane.

In the recovery phase of the process, called endocytosis, a new vesicle is pinched off from the donor cell surface and reloaded with neurotransmitter.

"This is a tightly coupled recycling process involving trillions of vesicles throughout the brain," says Chapman, based in the Department of Neuroscience. "As vesicles are consumed, if they are not immediately replaced, then you have a synapse that is not active anymore, and this is a problem."

The synaptophysin mystery had stayed in the back of Chapman's mind since he had been a graduate student in the late 1980s. When his current graduate student Sung E. Kwon said he wanted to apply some of the newest techniques to analyzing the problem, Chapman encouraged him to do it, despite the fact that other scientists had failed for years to find what synaptophysin does.

Using a mouse that had been genetically engineered to have no synaptophysin, Kwon attached a fluorescent tag to a vesicle protein so he could study the exocytosis-endocytosis cycle optically. He also used electrophysiological methods to analyze signaling in normal versus synaptophysin-free vesicles.

The experiments showed that the lack of synaptophysin had no effect on exocytosis, but produced a clear-cut deficit in the recycling of vesicles during endocytosis. Kwon was able to confirm the effect when he inserted synaptophysin and regained normal endocytosis.

"We found that synaptophysin regulates two distinct phases of endocytosis in synaptic vesicles, both during and after sustained neuronal activity," Kwon says. "Lack of synaptophysin delayed the replenishment of usable vesicles."

The defect may help explain why people with synaptophysin mutations may have mental retardation, he says.

"It will take more studies to directly link how this cycling defect leads to mental retardation, but we now have a good starting point," Kwon says.

Scientists could also now begin to screen for molecules that could override the defect and restore normal rates of endocytosis, adds Chapman.

"You can't do anything like that until you know what the protein does," he says. "And now we do."


Story Source:

The above story is based on materials provided by University of Wisconsin-Madison. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sung E. Kwon, Edwin R. Chapman. Synaptophysin Regulates the Kinetics of Synaptic Vesicle Endocytosis in Central Neurons. Neuron, 2011; 70 (5): 847-854 DOI: 10.1016/j.neuron.2011.04.001

Cite This Page:

University of Wisconsin-Madison. "Membrane protein mystery solved: May lead to better treatments for people with learning deficits." ScienceDaily. ScienceDaily, 10 June 2011. <www.sciencedaily.com/releases/2011/06/110608122546.htm>.
University of Wisconsin-Madison. (2011, June 10). Membrane protein mystery solved: May lead to better treatments for people with learning deficits. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/06/110608122546.htm
University of Wisconsin-Madison. "Membrane protein mystery solved: May lead to better treatments for people with learning deficits." ScienceDaily. www.sciencedaily.com/releases/2011/06/110608122546.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins